Sulfadoxine-Pyrimethamine with Amodiaquine (SPAQ)
![Photo: Toby Madden/MMV Photo: Toby Madden/MMV](https://www.smc-alliance.org/sites/mmv-smc/files/styles/nugget-mobile/public/content/paragraphs/text/images/2020-09-25/SPAQ.jpg?itok=tFe1SK7D×tamp=1601025090)
SMC is administered using co-blistered sulfadoxine-pyrimethamine (SP) together with amodiaquine (AQ). This combination was chosen due to its ability to provide relatively long-lasting protection.
SPAQ is currently dosed at monthly intervals for three to five months during the rainy season. This combination is a successful example of the re-purposing of two antimalarial drugs.